MABEL

A Parallel Group, Double-blind, Randomised, Placebo-controlled Trial Comparing The Effectiveness And Cost Effectiveness Of Low Dose Oral Modified Release Morphine Versus Placebo On Patient-reported Worst Breathlessness In People With Chronic Breathlessness: Morphine And BrEathLessness Trial

The main aim of this study is to establish if giving regular, low dose morphine capsules twice a day are better than placebo (dummy) for chronic breathlessness and whether morphine improves daily activity.

Chief Investigator: Marie Fallon

EudraCT number: 2019-002479-33

ISRCTN number: ISRCTN87329095 

Funder: National Institute for Health Research

 

Start and End date

Of grant award: 01 March 2019 - 28 February 2025

Of recruitment: N/A

 

Current Status: Open

 

Trial Website: N/A

 

UK GDPR Privacy Statement: As part of Patient Information sheet

 

ECTU involvement: Statistics / Health Economics

 

This article was published on